Your browser doesn't support javascript.
One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar.
Benslimane, Fatiha M; Al Khatib, Hebah A; Al-Jamal, Ola; Albatesh, Dana; Boughattas, Sonia; Ahmed, Ayeda A; Bensaad, Meryem; Younuskunju, Shameem; Mohamoud, Yasmin A; Al Badr, Mashael; Mohamed, Abdalla A; El-Kahlout, Reham A; Al-Hamad, Tasneem; Elgakhlab, Dina; Al-Kuwari, Fatima H; Saad, Chadi; Jeremijenko, Andrew; Al-Khal, Abdullatif; Al-Maslamani, Muna A; Bertollini, Roberto; Al-Kuwari, Einas A; Al-Romaihi, Hamad E; Al-Marri, Salih; Al-Thani, Mohammed; Badji, Radja M; Mbarek, Hamdi; Al-Sarraj, Yasser; Malek, Joel A; Ismail, Said I; Abu-Raddad, Laith J; Coyle, Peter V; Thani, Asmaa A Al; Yassine, Hadi M.
  • Benslimane FM; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Al Khatib HA; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Al-Jamal O; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Albatesh D; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Boughattas S; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Ahmed AA; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Bensaad M; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Younuskunju S; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Mohamoud YA; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Al Badr M; National Reference Laboratory Ministry of Public Health, Doha, Qatar.
  • Mohamed AA; National Reference Laboratory Ministry of Public Health, Doha, Qatar.
  • El-Kahlout RA; Hamad Medical Corporation, Doha, Qatar.
  • Al-Hamad T; Qatar Biobank, Doha, Qatar.
  • Elgakhlab D; Qatar Biobank, Doha, Qatar.
  • Al-Kuwari FH; Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar.
  • Saad C; Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar.
  • Jeremijenko A; Hamad Medical Corporation, Doha, Qatar.
  • Al-Khal A; Hamad Medical Corporation, Doha, Qatar.
  • Al-Maslamani MA; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Bertollini R; Ministry of Public Health, Doha, Qatar.
  • Al-Kuwari EA; Hamad Medical Corporation, Doha, Qatar.
  • Al-Romaihi HE; Ministry of Public Health, Doha, Qatar.
  • Al-Marri S; Ministry of Public Health, Doha, Qatar.
  • Al-Thani M; Ministry of Public Health, Doha, Qatar.
  • Badji RM; Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar.
  • Mbarek H; Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar.
  • Al-Sarraj Y; Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar.
  • Malek JA; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Ismail SI; Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Abu-Raddad LJ; Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar.
  • Coyle PV; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Thani AAA; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, United States.
  • Yassine HM; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Doha, Qatar.
Front Cell Infect Microbiol ; 11: 768883, 2021.
Article in English | MEDLINE | ID: covidwho-1555159
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
Qatar, a country with a strong health system and a diverse population consisting mainly of expatriate residents, has experienced two large waves of COVID-19 outbreak. In this study, we report on 2634 SARS-CoV-2 whole-genome sequences from infected patients in Qatar between March-2020 and March-2021, representing 1.5% of all positive cases in this period. Despite the restrictions on international travel, the viruses sampled from the populace of Qatar mirrored nearly the entire global population's genomic diversity with nine predominant viral lineages that were sustained by local transmission chains and the emergence of mutations that are likely to have originated in Qatar. We reported an increased number of mutations and deletions in B.1.1.7 and B.1.351 lineages in a short period. These findings raise the imperative need to continue the ongoing genomic surveillance that has been an integral part of the national response to monitor the SARS-CoV-2 profile and re-emergence in Qatar.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Asia Language: English Journal: Front Cell Infect Microbiol Year: 2021 Document Type: Article Affiliation country: Fcimb.2021.768883

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Asia Language: English Journal: Front Cell Infect Microbiol Year: 2021 Document Type: Article Affiliation country: Fcimb.2021.768883